| Net Cash Provided by (Used in) Operating Activities |
$105,821,000 |
USD |
66% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$108,057,000 |
USD |
-68% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
190,910,860 |
shares |
61% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,236,000 |
USD |
-92% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$216,481,000 |
USD |
234% |
Q4 2024 |
FY 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$59,148,000 |
USD |
230% |
Q1 2024 |
Q1 2024 |
| Additional Paid in Capital |
$2,874,535,000 |
USD |
66% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$200,082,000 |
USD |
54% |
Q4 2024 |
FY 2024 |